C. Ericson
Impact in
-
- Cancer, Lipids, and Metabolism
- Protease and Inhibitor Mechanisms
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 9
- Lipoproteins and Cardiovascular Health 8
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
- Co-authors
- G. Dahlén (15 shared papers)K. Berg (4 shared papers)K. Berg (2 shared papers)L Lundkvist (3 shared papers)Curt D. Furberg (6 shared papers)C.D. Furberg (1 shared paper)Kurt Svärdsudd (1 shared paper)Kurt Svärdsudd (2 shared papers)
In The Last Decade
C. Ericson
17 papers receiving 410 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 141
- Endocrinology, Diabetes and Metabolism 134
- Surgery 310
- Cardiology and Cardiovascular Medicine 94
- Immunology and Allergy 22
Countries citing papers authored by C. Ericson
This map shows the geographic impact of C. Ericson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ericson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ericson more than expected).
Fields of papers citing papers by C. Ericson
This network shows the impact of papers produced by C. Ericson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ericson. The network helps show where C. Ericson may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Ericson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 102 | |
| 2 | Studies on an extra pre-beta lipoprotein fraction. | 1972 | 68 |
| 3 | 1978 | 49 | |
| 4 | 2017 | 28 | |
| 5 | 1983 | 27 | |
| 6 | 1978 | 26 | |
| 7 | The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). | 1981 | 25 |
| 8 | 1974 | 24 | |
| 9 | 1972 | 24 | |
| 10 | 1991 | 17 | |
| 11 | 1977 | 15 | |
| 12 | Effect of gemfibrozil on serum lipid levels. | 1980 | 14 |
| 13 | 1972 | 13 | |
| 14 | 1972 | 5 | |
| 15 | 1972 | 4 | |
| 16 | 1975 | 3 | |
| 17 | 1972 | 2 |
About C. Ericson
C. Ericson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 446 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Cancer, Lipids, and Metabolism (3 papers), Cell Adhesion Molecules Research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), RNA and protein synthesis mechanisms (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Ion channel regulation and function (1 paper) and Nutrition, Genetics, and Disease (1 paper). The work is most often cited by research in Cancer Research (141 citations), Endocrinology, Diabetes and Metabolism (134 citations), Surgery (310 citations), Cardiology and Cardiovascular Medicine (94 citations) and Immunology and Allergy (22 citations). C. Ericson has collaborated with scholars based in Sweden, Norway and Finland. Frequent co-authors include G. Dahlén, K. Berg, K. Berg, L Lundkvist, Curt D. Furberg, C.D. Furberg, Kurt Svärdsudd, Kurt Svärdsudd, M. H. Frick and Ulf dé Fairé. Their work appears in journals such as Clinical Genetics, Journal of ExtraCorporeal Technology, The American Journal of Emergency Medicine, International Journal of Epidemiology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.